Custom Search
Fluvastatin News
Statins can inhibit the replication of the hepatitis C virus, may replace ribavirin in combination therapy
A new study shows that statins, which are typically used as anti-cholesterol medications, can inhibit the replication of the hepatitis C virus (HCV). They could replace ribavirin in combination therapy with interferon.
Reports from the United States and Canada describe recent advances in statins research
Data on statins are outlined in reports from the United States and Canada.
Biovail to promote Novartis' Lescol franchise in Canada
Biovail Corp. (BVF) announced that Biovail Pharmaceuticals Canada (BPC), the company's Canadian sales and marketing division, has entered into an agreement with Novartis Pharmaceuticals Canada, Inc., a wholly owned subsidiary of...
Displaying results 6 to 8 out of 8